Julia T. De Castro
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum to "Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19" [Vaccine 64 (2025) 127756].
Journal: Vaccine
Published: February 12, 2026
Correction: RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response.
Journal: Frontiers in cellular and infection microbiology
Published: October 20, 2025
RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response.
Journal: Frontiers in cellular and infection microbiology
Published: August 07, 2025
SpiN-Tec: A T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern.
Journal: Vaccine
Published: December 12, 2023
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine.
Journal: Nanomedicine (London, England)
Published: September 15, 2023
Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi Parasites.
Journal: mBio
Published: January 25, 2022
Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage.
Journal: PLoS pathogens
Published: December 02, 2019
The emergence of pathogenic TNF/iNOS producing dendritic cells (Tip-DCs) in a malaria model of acute respiratory distress syndrome (ARDS) is dependent on CCR4.
Journal: Mucosal immunology
Published: March 09, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026